Test Price
2,800 AED✅ Home Collection Available
NTRK1 Gene HSAN4 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين NTRK1 لمرض الاعتلال العصبي الحسي واللاإرادي من النوع الرابع (HSAN4) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
ملخص تنفيذي: يوفر اختبار تسلسل الجين الكامل NTRK1 باستخدام تقنية التسلسل الجيني من الجيل التالي (NGS) تشخيصًا دقيقًا لمرض الاعتلال العصبي الحسي واللاإرادي الوراثي من النوع الرابع (HSAN4)، مع ضمان دقة تصل إلى 99.9% عبر مختبر معتمد من هيئة الصحة بدبي وبشهادة ISO 9001:2015. تشمل الخدمة سحب العينة منزليًا من قبل ممرضين مرخصين، مع استشارة سريرية بعد النتيجة، والتحقق الفوري من التغطية التأمينية عبر واتساب.
- ✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing (ISO 9001:2015 Cert: INT/EGQ/2509DA/3139).
- ✅ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection, available 8 AM – 11 PM.
- ✅ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed clinicians.
- ✅ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview of NTRK1 Gene HSAN4 Test
The NTRK1 Gene HSAN4 Genetic Test identifies pathogenic variants in the NTRK1 gene causing Hereditary Sensory and Autonomic Neuropathy Type IV (HSAN4), a rare autosomal recessive disorder characterized by congenital insensitivity to pain and anhidrosis. يكشف التحليل طفرات جين NTRK1 المسؤولة عن ضعف الإحساس بالألم والتعرق، مما يتيح تشخيصًا مبكرًا وخطة علاجية مخصصة. Our next-generation sequencing (NGS) panel covers all exonic and flanking intronic regions with a turnaround time of 3–4 weeks, at a cost of 2800 AED.
| Feature | Our NGS Test | Standard Sanger Sequencing |
|---|---|---|
| Precision | 99.9% sensitivity, full gene coverage | Limited to pre-defined hotspot mutations |
| Method | Next-Generation Sequencing (NGS) with Sanger confirmation | Sanger sequencing only |
| Speed | 3–4 weeks | 4–6 weeks |
| Price | 2800 AED | Not routinely offered in UAE; higher cost |
Physician Insight & Safety Protocol
“As a neurologist, I emphasize that a positive NTRK1 result should always be interpreted in the context of clinical findings and family history. This test can confirm the diagnosis of HSAN4, but it is not a substitute for comprehensive neurological evaluation. Always correlate genetic data with your patient’s symptoms and consider genetic counseling before and after testing.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
⚠️ Medication Warning:
Do not discontinue prescribed medication or alter treatment without consulting your doctor. The results of this genetic test do not provide a complete clinical picture and are not intended to guide immediate therapeutic changes.
Exclusion Criteria & Emergency Red Flags
Test Exclusion Criteria
- Patients unable to provide a blood sample or with severe coagulation disorders.
- Recipients of allogeneic bone marrow transplantation (may yield donor DNA).
- Individuals unwilling to undergo pre-test genetic counseling (required under UAE CDS Law 2026 for minors).
🚨 Seek Emergency Care If:
- The patient experiences hyperthermia (>39°C) with absent sweating, indicating anhidrosis crisis.
- Unexplained fractures or injuries that go unnoticed due to pain insensitivity.
- Signs of severe infection or corneal ulceration in infants/children.
Patient FAQ & Clinical Guidance
Regulatory Compliance: This adheres to UAE Federal Decree-Law No. 41 of 2024 (Art. 87) on health data privacy, the UAE CDS Law 2026 (minors require guardian consent and genetic counseling), and PDPL. Accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) by DHA facility license no. 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians